IVIXF (Invion) Other Operating Expense: $3.73 Mil (TTM As of Dec. 2025)


IVIXF Invion Ltd IVIXF
16 GF Score
Price $0.04
GF Value $0.21
! 1 Warning Sign
View Full Analysis

What is Invion Other Operating Expense?

Invion IVIXF -83.23% 16 Other Operating Expense is $3.73 Mil as of Dec. 2025. GuruFocus rates IVIXF with a GF Score™ of 16/100 and a GF Value™ of $0.21. The stock has 1 warning sign investors should review.

Invion's Other Operating Expense for the six months ended in Dec. 2025 was $0.57 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $3.73 Mil.

Invion's quarterly Other Operating Expense increased from Dec. 2024 ($0.26 Mil) to Jun. 2025 ($3.16 Mil) but then declined from Jun. 2025 ($3.16 Mil) to Dec. 2025 ($0.57 Mil).

Invion's annual Other Operating Expense increased from Jun. 2023 ($1.74 Mil) to Jun. 2024 ($3.28 Mil) and increased from Jun. 2024 ($3.28 Mil) to Jun. 2025 ($3.43 Mil).

Invion Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Invion's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invion Other Operating Expense Chart

Invion Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 1.62 1.74 3.28 3.43

Invion Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 3.01 0.26 3.16 0.57
IVIXF
16GF Score
Invion Ltd IVIXF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invion Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $3.73 Mil mean?
Invion (IVIXF) has a Other Operating Expense of $3.73 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Invion and its competitors.
Is Invion's Other Operating Expense too high?
Invion's current Other Operating Expense is $3.73 Mil. Overall, Invion has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Invion's Other Operating Expense compare to ZTS and UTHR?
Invion's Other Operating Expense of $3.73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Invion and its competitors. Invion's current Other Operating Expense is $3.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invion stock overvalued right now?
Invion (IVIXF) has a current Other Operating Expense of $3.73 Mil. The stock's GF Value™ is $0.21, compared to a current price of $0.04 — trading 82.4% below its estimated fair value. The current Other Operating Expense is $3.73 Mil. Invion's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Invion (IVIXF), the current Other Operating Expense is $3.73 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Invion (IVIXF) Overvalued in 2026?

Based on GuruFocus' analysis, Invion stock appears to be undervalued. The current stock price of $0.04 is trading 82.4% below its estimated GF Value™ of $0.21.

Key valuation signals for IVIXF:

  • Other Operating Expense: $3.73 Mil
  • GF Value™: $0.21 vs. price of $0.04 (82.4% below fair value)
  • GF Score™: 16/100 with 1 warning sign

No single metric tells the full story. See the IVIXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Invion Business Description

Other Exchanges 7C8:GermanyIVX:Australia
Address 692 High Street, East Kew, VIC, AUS, 3102
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers, and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.
16GF Score

Get the complete analysis for IVIXF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.04
Price
$0.21
GF Value